Supplements (dietary supplements; vital substances) Appropriate dietary supplements should contain the following vital substances: Vitamins (A, C, D3, E, B 1, B 2, B 3, B 5, B 6, B 12, folic acid, biotin). Minerals (magnesium) Trace elements (iodine, molybdenum, selenium, zinc) Omega-3 fatty acids (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)). Secondary plant compounds … Benign Prostatic Hyperplasia: Drug Therapy
Mandatory medical device diagnostics. Residual urine determination by ultrasound Ultrasound diagnosis of kidneys, bladder and prostate – to determine the size of the prostate; exclusion of already occurred kidney damage or to exclude stones, tumors, etc.. Uroflowmetry (including determination of maximum urine flow (Qmax) and creation of a urine flow curve) – to determine the … Benign Prostatic Hyperplasia: Diagnostic Tests
Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for prevention: Vitamin C Beta-carotene Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for supportive therapy: Vitamin E Beta-sitosterol Saw palmetto (Serenoa repens, Synoynm: Sabal serrulata; saw palmetto) belongs to the palm family … Benign Prostatic Hyperplasia: Micronutrient Therapy
To prevent benign prostatic hypertrophy (BPH; prostate enlargement), attention must be paid to reducing individual risk factors. Behavioral risk factors Diet Micronutrient deficiency (vital substances) – see Prevention with micronutrients. Physical activity Sitting for long periods ≥ 10 hours per day (+16% increased risk of LUTS (Lower Urinary Tract Symptoms)).
The enlargement of the prostate increasingly narrows the urethra (benign prostatic obstruction (BPO; bladder outlet obstruction, BOO), which leads to disturbances during urination. The bladder has to work against the resistance (= increase in bladder outlet resistance) and the muscles thicken. If the constriction persists for a long time, the bladder can no longer empty … Benign Prostatic Hyperplasia: Symptoms, Complaints, Signs
Pathogenesis (development of disease) The cause of benign (benign) prostatic hyperplasia (prostate enlargement) is still unknown. Various hypotheses are discussed that may lead to the hyperplasia: Influence of growth factors Dihydrotestosterone hypothesis (DHT hypothesis): Increased intracellular DHT levels. Increased 5-alpha-reductase activity Increased androgen receptor levels Increased estrogen serum levels with concomitant low testosterone serum levels. … Benign Prostatic Hyperplasia: Causes
Recommendations listed below are essentially to support treatment for men with lower urinary tract symptoms (LUTS). For mild symptoms, lifestyle changes may already control symptoms. General Measures Less sedentary behavior and more physical activity may potentially counteract lower urinary tract symptoms (LUTS). In patients with LUTS, the sitting position during micturition (urination) has a positive … Benign Prostatic Hyperplasia: Therapy
A comprehensive clinical examination is the basis for selecting further diagnostic steps: General physical examination – including blood pressure, pulse, body weight, height; further: Inspection (viewing). Skin and mucous membranes Abdomen (abdomen) Shape of the abdomen? Skin color? Skin texture? Efflorescences (skin changes)? Pulsations? Bowel movements? Visible vessels? Scars? Hernias (fractures)? Genital Palpation (palpation) of … Benign Prostatic Hyperplasia: Examination
The diagnosis of benign prostatic hypertrophy (BPH) is made on the basis of the clinical picture and the results of medical device diagnostics.2nd-order laboratory parameters-depending on the results of the history, physical examination, and medical device diagnostics-are used for differential diagnostic clarification PSA (prostate specific antigen) Caution. There are PSA-negative prostate carcinomas. Urine status (rapid … Benign Prostatic Hyperplasia: Test and Diagnosis
Medical history (history of illness) represents an important component in the diagnosis of benign prostatic hyperplasia (BPH; benign prostatic enlargement). Family history Social history Current anamnesis/systemic anamnesis (somatic and psychological complaints). Do you have an urge to urinate frequently without increased urination? Do you have involuntary leakage of urine under urge to urinate? Is the … Benign Prostatic Hyperplasia: Medical History
Neoplasms – Tumor Diseases (C00-D48). Prostate carcinoma (prostate cancer). Genitourinary system (kidneys, urinary tract – reproductive organs) (N00-N99). Granulomatous prostatitis – inflammation of the prostate gland with formation of granulomas (tissue nodules) after secretion stasis. Prostate abscess – accumulation of pus in the prostate gland. Prostatodynia – non-inflammatory pain syndrome of the prostate gland. Various … Benign Prostatic Hyperplasia: Or something else? Differential Diagnosis
The following are the most important diseases or complications that may be caused by benign prostatic hyperplasia (BPH; benign prostatic enlargement): Genitourinary system (kidneys, urinary tract-genital organs) (N00-N99). Benign prostatic obstruction (BPO; bladder outlet obstruction, BOO bladder outlet obstruction; increase in bladder outlet resistance). Urge incontinence (synonym: urge incontinence) – bladder storage disorder: bladder sphincter … Benign Prostatic Hyperplasia: Complications
